|
Re: For Scientists - Nature article/study on epigenetic changes after kidney injury
|
3
|
Resverlogix Corp.
|
Jul 28, 2020 10:45AM
|
|
Re: The importance of sub-group analyses
|
3
|
Resverlogix Corp.
|
Dec 18, 2018 08:42PM
|
|
Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV
|
3
|
Resverlogix Corp.
|
Jul 24, 2019 03:20PM
|
|
Re: Trial
|
3
|
Zenith Epigenetics
|
Sep 07, 2016 11:48AM
|
|
Nuevolution and bromodomain selective BET inhibitors
|
3
|
Zenith Epigenetics
|
Nov 27, 2017 12:54PM
|
|
Re: Zenith Epigenetics Corp. Commences Operations
|
3
|
Zenith Epigenetics
|
Dec 08, 2015 01:02PM
|
|
Re: DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
3
|
Resverlogix Corp.
|
Mar 28, 2019 01:22PM
|
|
Bioasis Announces FDA Response to Pre-IND Submission
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 25, 2019 05:09PM
|
|
Nuevolution and bromodomain selective BET inhibitors
|
3
|
Resverlogix Corp.
|
Nov 27, 2017 12:55PM
|
|
Re: The waiting game.....
|
3
|
Resverlogix Corp.
|
Jan 17, 2019 11:45AM
|
|
Re: The waiting game.....
|
3
|
Resverlogix Corp.
|
Jan 24, 2019 09:52AM
|
|
Re: Notice of Meeting and Management Information Circular Posted
|
3
|
Zenith Epigenetics
|
Sep 28, 2019 07:53AM
|
|
Re: AHA Late Breaker!
|
3
|
Resverlogix Corp.
|
Sep 20, 2019 01:08PM
|
|
Re: Notice of Meeting and Management Information Circular Posted
|
3
|
Resverlogix Corp.
|
Sep 28, 2019 07:54AM
|
|
Re: Q4 2019 Events
|
3
|
Resverlogix Corp.
|
Oct 07, 2019 08:56PM
|
|
Re: DSMB 7th review??
|
3
|
Resverlogix Corp.
|
Jul 20, 2018 10:18AM
|
|
Re: RVX files notice of meeting...
|
3
|
Resverlogix Corp.
|
May 18, 2015 11:34AM
|
|
Re: Could there be another shoe waiting to drop?
|
3
|
Resverlogix Corp.
|
May 20, 2019 06:07PM
|
|
Re: orphan diseases
|
3
|
Resverlogix Corp.
|
Jul 01, 2018 09:19AM
|
|
Re: Glucose fluctuation
|
3
|
Resverlogix Corp.
|
Jun 15, 2015 12:08PM
|
